Confocal microscopy of giant vesicles supports the absence of HIV-1 neutralizing 2F5 antibody reactivity to plasma membrane phospholipids

FEBS Letters

Volumn 584, Issue 8, 2010, Pages 1591-1596

  Apellaniz, Beatriz ^a   García Sáez, Ana J ^b   Huarte, Nerea ^a   Kunert, Renate ^c   Vorauer Uhl, Karola ^c   Katinger, Hermann ^c   Schwille, Petra ^b   Nieva, José L ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

Author keywords

2F5; Broadly neutralizing antibody; Gp41; HIV 1 neutralization; Membrane proximal external region; Passive immunotherapy; Peptide vaccine

Indexed keywords

EPITOPE; GLYCOPROTEIN GP 41; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; MEMBRANE PHOSPHOLIPID; MONOCLONAL ANTIBODY 2F5;

ARTICLE; CELL SURFACE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS 1; LIPID BILAYER; LIPID RAFT; MEMBRANE BINDING; MEMBRANE PERMEABILITY; MOLECULAR RECOGNITION; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; SURFACE CHARGE; VIRUS NEUTRALIZATION;

AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; ANTIBODY SPECIFICITY; CELL MEMBRANE; EPITOPES; FLOW CYTOMETRY; HIV-1; LIPID BILAYERS; MEMBRANE MICRODOMAINS; MICROSCOPY, CONFOCAL; MOLECULAR SEQUENCE DATA; PEPTIDES; PHOSPHOLIPIDS; PHYSICOCHEMICAL PROCESSES; UNILAMELLAR LIPOSOMES;

EUKARYOTA; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 77951296711     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2010.03.021     Document Type: Article

References (32)

1. Zwick M.B. The membrane-proximal external region of HIV-1 gp41: a vaccine target worth exploring. AIDS 2005, 19:1725-1737.
2. Montero M., van Houten N.E., Wang X., Scott J.K. The membrane-proximal external region of the human immunodeficiency virus type 1 envelope: dominant site of antibody neutralization and target for vaccine design. Microbiol. Mol. Biol. Rev. 2008, 72:54-84.
3. Lorizate M., Huarte N., Saez-Cirion A., Nieva J.L. Interfacial pre-transmembrane domains in viral proteins promoting membrane fusion and fission. Biochim. Biophys. Acta 2008, 1778:1624-1639.
4. Stiegler G., Katinger H. Therapeutic potential of neutralizing antibodies in the treatment of HIV-1 infection. J. Antimicrob. Chemother. 2003, 51:757-759.
5. Ofek G., Tang M., Sambor A., Katinger H., Mascola J.R., Wyatt R., Kwong P.D. Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope. J. Virol. 2004, 78:10724-10737.
6. Sanchez-Martinez S., Lorizate M., Katinger H., Kunert R., Nieva J.L. Membrane association and epitope recognition by HIV-1 neutralizing anti-gp41 2F5 and 4E10 antibodies. AIDS Res. Hum. Retroviruses 2006, 22:998-1006.
7. Huarte N., Lorizate M., Maeso R., Kunert R., Arranz R., Valpuesta J.M., Nieva J.L. The broadly neutralizing anti-human immunodeficiency virus type 1 4E10 monoclonal antibody is better adapted to membrane-bound epitope recognition and blocking than 2F5. J. Virol. 2008, 82:8986-8996.
8. Song L., et al. Broadly neutralizing anti-HIV-1 antibodies disrupt a hinge-related function of gp41 at the membrane interface. Proc. Natl. Acad. Sci. USA 2009, 106:9057-9062.
9. Dennison S.M., Stewart S.M., Stempel K.C., Liao H.X., Haynes B.F., Alam S.M. Stable docking of neutralizing human immunodeficiency virus type 1 gp41 membrane-proximal external region monoclonal antibodies 2F5 and 4E10 is dependent on the membrane immersion depth of their epitope regions. J. Virol. 2009, 83:10211-10223.
10. Haynes B.F., et al. Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies. Science 2005, 308:1906-1908.
11. Nabel G.J. Immunology. Close to the edge: neutralizing the HIV-1 envelope. Science 2005, 308:1878-1879.
12. Vcelar B., et al. Reassessment of autoreactivity of the broadly neutralizing HIV antibodies 4E10 and 2F5 and retrospective analysis of clinical safety data. AIDS 2007, 21:2161-2170.
13. Scherer E.M., Zwick M.B., Teyton L., Burton D.R. Difficulties in eliciting broadly neutralizing anti-HIV antibodies are not explained by cardiolipin autoreactivity. AIDS 2007, 21:2131-2139.
14. Alving C.R. 4E10 and 2F5 monoclonal antibodies: binding specificities to phospholipids, tolerance, and clinical safety issues. AIDS 2008, 22:649-651.
15. van Meer G. Cellular lipidomics. EMBO J. 2005, 24:3159-3165.
16. McIntosh T.J., Simon S.A. Bilayers as protein solvents: role of bilayer structure and elastic properties. J. Gen. Physiol. 2007, 130:225-227.
17. Coskun, Ü. and Simons, K. (2010) Membrane rafting: from apical sorting to phase segregation. FEBS Lett., doi:10.1016/j.febslet.2009.12.043.
18. Lingwood D., Simons K. Lipid rafts as a membrane-organizing principle. Science 2010, 327:46-50.
19. Buchacher A., et al. Generation of human monoclonal antibodies against HIV-1 proteins; electrofusion and Epstein-Barr virus transformation for peripheral blood lymphocyte immortalization. AIDS Res. Hum. Retroviruses 1994, 10:359-369.
20. Kunert R., Steinfellner W., Purtscher M., Assadian A., Katinger H. Stable recombinant expression of the anti HIV-1 monoclonal antibody 2F5 after IgG3/IgG1 subclass switch in CHO cells. Biotechnol. Bioeng. 2000, 67:97-103.
21. Garcia-Saez A.J., Ries J., Orzaez M., Perez-Paya E., Schwille P. Membrane promotes tBID interaction with BCL(XL). Nat. Struct. Mol. Biol. 2009, 16:1178-1185.
22. Garcia-Saez A.J., Chiantia S., Salgado J., Schwille P. Pore formation by a Bax-derived peptide: effect on the line tension of the membrane probed by AFM. Biophys. J. 2007, 93:103-112.
23. Garcia-Saez A.J., Chiantia S., Schwille P. Effect of line tension on the lateral organization of lipid membranes. J. Biol. Chem. 2007, 282:33537-33544.
24. Sanchez-Martinez S., Lorizate M., Hermann K., Kunert R., Basanez G., Nieva J.L. Specific phospholipid recognition by human immunodeficiency virus type-1 neutralizing anti-gp41 2F5 antibody. FEBS Lett. 2006, 580:2395-2399.
25. Alam S.M., et al. The role of antibody polyspecificity and lipid reactivity in binding of broadly neutralizing anti-HIV-1 envelope human monoclonal antibodies 2F5 and 4E10 to glycoprotein 41 membrane proximal envelope epitopes. J. Immunol. 2007, 178:4424-4435.
26. Matyas G.R., Beck Z., Karasavvas N., Alving C.R. Lipid binding properties of 4E10, 2F5, and WR304 monoclonal antibodies that neutralize HIV-1. Biochim. Biophys. Acta 2009, 1788:660-665.
27. Zwick M.B., Jensen R., Church S., Wang M., Stiegler G., Kunert R., Katinger H., Burton D.R. Anti-human immunodeficiency virus type 1 (HIV-1) antibodies 2F5 and 4E10 require surprisingly few crucial residues in the membrane-proximal external region of glycoprotein gp41 to neutralize HIV-1. J. Virol. 2005, 79:1252-1261.
28. Vishwanathan S.A., Hunter E. Importance of the membrane-perturbing properties of the membrane-proximal external region of human immunodeficiency virus type 1 gp41 to viral fusion. J. Virol. 2008, 82:5118-5126.
29. Schon P., Garcia-Saez A.J., Malovrh P., Bacia K., Anderluh G., Schwille P. Equinatoxin II permeabilizing activity depends on the presence of sphingomyelin and lipid phase coexistence. Biophys. J. 2008, 95:691-698.
30. Baumgart T., Hess S.T., Webb W.W. Imaging coexisting fluid domains in biomembrane models coupling curvature and line tension. Nature 2003, 425:821-824.
31. Loose M., Schwille P. Biomimetic membrane systems to study cellular organization. J. Struct. Biol. 2009, 168:143-151.
32. Brugger B., Glass B., Haberkant P., Leibrecht I., Wieland F.T., Krausslich H.G. The HIV lipidome: a raft with an unusual composition. Proc. Natl. Acad. Sci. USA 2006, 103:2641-2646.